Those differences are probably
genetic.
那些大概是遗传上的差别。
It's very hard to treat
genetic diseases.
遗传性疾病治疗起来很困难。
It is not clear whether this is due to
genetic changes in the virus, or to other factors like the weather.
目前尚不清楚造成此现象的原因是病毒的基因变化还是天气等其他因素。
Genetic diversity is crucial for the survival of species.
遗传多样性对于物种的生存至关重要。
Scientists have mapped the human genome, revealing the blueprint of our
genetic makeup.
科学家已经绘制了人类基因组，揭示了我们遗传构成的蓝图。
The gene responsible for lactose tolerance is common in people of European descent.
乳糖耐受的基因在欧洲血统的人中很常见。
Genetic testing can help identify individuals at risk for inherited diseases.
基因检测有助于识别有遗传疾病风险的个体。
Through
genetic engineering, scientists can modify organisms to produce desired traits or substances.
通过基因工程，科学家可以改变生物体以产生所需的特性或物质。
Heritability refers to the extent to which traits are influenced by
genetics versus environmental factors.
遗传性是指特质在多大程度上受遗传因素而非环境因素影响。
They conducted a study on twins to analyze the role of nature vs. nurture in their
genetic development.
他们对双胞胎进行了研究，分析了遗传和后天养育在他们发育中的作用。
Genetic counseling helps individuals and families understand their risk for passing on
genetic disorders.
遗传咨询帮助个人和家庭了解他们传递遗传疾病的潜在风险。
The discovery of epi
genetics has expanded our understanding of how genes can be turned on or off without changing their DNA sequence.
表观遗传学的发现扩展了我们对基因如何在不改变DNA序列的情况下开启或关闭的理解。
Scientists are working on gene editing technologies like CRISPR to correct or prevent
genetic mutations causing diseases.
科学家正在研究CRISPR等基因编辑技术来修复或预防导致疾病的遗传突变。
"Different from genetically modified rice, perennial rice takes advantage of the rice's hybridity and natural variation, without changing its genetic structure.
与转基因水稻不同，多年生水稻利用了水稻的杂交性和自然变异性，而不改变其遗传结构。
"However, attention should be paid to aspects including genetic safety, diversity of species, as well as ecological ethics, to make sure technology is used in the right way," he said.
他说：“然而，应该关注基因安全、物种多样性以及生态伦理等方面，以确保技术以正确的方式使用。”。
The Global Lighthouse Network is a community of manufacturers applying advanced technologies to speed up and spread the smart adoption of fourth-industrial revolution technologies — a fusion of artificial intelligence, robotics, the internet of things, blockchain, 3D printing, genetic engineering, quantum computing and other technologies — to their industries worldwide.
全球灯塔网络是一个应用先进技术的制造商社区，旨在加快第四次工业革命技术的智能应用，并将其传播到全球行业。第四次产业革命技术融合了人工智能、机器人、物联网、区块链、3D打印、基因工程、量子计算和其他技术。
Formed by more than 130 plants owned by various companies to date, it is a community of manufacturers applying advanced technologies to speed up and spread the smart adoption of Fourth Industrial Revolution technologies — a fusion of artificial intelligence, robotics, the internet of things, Web3, blockchain, 3D printing, genetic engineering, quantum computing and other technologies — to their industries worldwide.
迄今为止，它由多家公司拥有的130多家工厂组成，是一个制造商社区，应用先进技术加快和传播第四次工业革命技术的智能应用——人工智能、机器人、物联网、Web3、区块链、3D打印、基因工程，量子计算和其他技术——应用于全球范围内的行业。
Illumina, a global leader in DNA sequencing and array-based technologies, is expected to reach a series of strategic cooperation intention agreements with nearly 30 Chinese genetic testing companies and business partners at the ongoing fifth China International Import Expo.
全球DNA测序和阵列技术领导者Illumina预计将在正在举行的第五届中国国际进口博览会上与近30家中国基因检测公司和商业伙伴达成一系列战略合作意向协议。
"Our new manufacturing site in China signifies Illumina's commitment to the country's life sciences and genetic industry," said Li Qing, senior vice-president and China general manager at Illumina, during a media briefing on Aug 25.
8月25日，Illumina高级副总裁兼中国区总经理李青在一次媒体吹风会上表示：“我们在中国的新生产基地标志着Illumina对国家生命科学和基因产业的承诺。”。
"According to Li, genetic sequencing could be the beginning of a revolution for the industry.
李表示，基因测序可能是该行业革命的开端。
Sinopharm is the only enterprise in the world to have independently developed four COVID-19 vaccines via three technical platforms－two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是世界上唯一一家通过三个技术平台自主研发4种新冠肺炎疫苗的企业——两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗。
Sinopharm is the only enterprise in the world that has independently developed four COVID-19 vaccines via three technical platforms -- two inactivated vaccines, one genetic recombinant vaccine and one mRNA vaccine.
国药集团是全球唯一一家通过两种灭活疫苗、一种基因重组疫苗和一种mRNA疫苗三大技术平台自主研发四种新冠肺炎疫苗的企业。
Taking the 4 million new cancer patients in the country every year into account, every year, more than 2.5 million Chinese cancer patients can take symptomatic drugs through genetic testing, choose suitable targeted drugs or immune drugs, prolong their survival period and obtain a higher quality of life.
考虑到全国每年新增癌症患者400万人，每年有250多万中国癌症患者可以通过基因检测服用有症状的药物，选择合适的靶向药物或免疫药物，延长生存期，获得更高的生活质量。
Sansure Biotech, a Changsha, Hunan province-based in-vitro diagnostic (IVD) product producer specializing in molecular diagnostics and genetic testing, is among those enjoying revenue spikes and technological upgrades amid surging demand for COVID-19 test kits.
在新冠肺炎检测试剂盒需求激增的情况下，专注于分子诊断和基因检测的湖南长沙体外诊断（IVD）产品生产商Sansure Biotech是收入激增和技术升级的公司之一。
Founded in 2008, the domestic leader in IVD modalities has an ambition to "make genetic technology-based high-end products and services accessible to all".
这家国内IVD领域的领导者成立于2008年，其目标是“让所有人都能获得基于基因技术的高端产品和服务”。
Berry Oncology, a leading Chinese company in genetic testing and early screening of tumors, plans to launch an early cancer screening product within the year that is capable in detecting six prevalent tumor types in China at one time, according to a senior executive of the company on Wednesday.
贝瑞肿瘤是中国领先的基因检测和肿瘤早期筛查公司，该公司一位高管周三表示，该公司计划在年内推出一种癌症早期筛查产品，能够一次检测出中国六种流行的肿瘤类型。
These assays will be developed based on the genetic analysis of the primary tumor from individual patients at the beginning of treatment.
这些检测将在治疗开始时根据个体患者原发肿瘤的基因分析进行开发。
There is soaring demand for risk assessment and early intervention for infectious and genetic diseases, cancer, and mental health issues," said Shen, noting digitalization has provided much better remote access and faster speed, and has become an increasingly important tool to reduce healthcare costs.
对传染病和遗传病、癌症和心理健康问题的风险评估和早期干预需求激增，”沈说，并指出数字化提供了更好的远程访问和更快的速度，并已成为降低医疗成本的日益重要的工具。
Genetron Holdings Limited, or Genetron Health, a Nasdaq-listed Chinese precision oncology platform company that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced on Monday its strategic partnership with NeoGenomics Inc, a US-based Nasdaq-listed company that specializes in cancer genetic testing and information services.
Genetron Holdings Limited，简称Genetron Health，是一家在纳斯达克上市的中国精准肿瘤平台公司，专门提供分子图谱检测、癌症早期筛查产品和配套诊断开发，美国纳斯达克上市公司，专门从事癌症基因检测和信息服务。
The partnership will combine the two companies' strengths to leverage a rich, diverse core technology platform and product pipeline that covers molecular detection, histopathologic diagnosis, multifluorescence immunohistochemistry, flow cytometry, immunoassays, in situ hybridization, and cell genetic mapping, Genetron Health said in a press release.
Genetron Health在一份新闻稿中表示，该合作伙伴关系将结合两家公司的优势，利用丰富多样的核心技术平台和产品线，涵盖分子检测、组织病理学诊断、多荧光免疫组织化学、流式细胞术、免疫测定、原位杂交和细胞基因图谱。
This year, the company is expected to sign agreements of intent with more than 30 Chinese genetic testing partners and ink strategic cooperation agreements with other multinational pharmaceutical companies and hospitals in multiple segments at the CIIE.
今年进博会上,该公司预计将与30多家中国基因检测合作方签署意向书,并与多家跨国药企及医院在多个领域达成战略合作。其中“CIIE”是“China International Import Expo”(中国国际进口博览会)的英文缩写。这段话的完整中文翻译如下：今年进博会上,该公司预计将与30多家中国基因检测合作方签署意向书,并与多家跨国药企及医院在多个领域达成战略合作。希望这个回答对您有帮助!
Founded in August 2017, the company grew out of the tumor business unit of Berry Genomics, one of China's largest companies in genetic testing, and has since established a wide range of genetic testing products and services for tumor patients and high-risk groups.
该公司成立于2017年8月，源自中国最大的基因检测公司之一贝瑞基因的肿瘤业务部门，自成立以来，已为肿瘤患者和高风险群体建立了广泛的基因检测产品和服务范围。
The company said it has cooperated with more than 700 hospitals nationwide to provide genetic testing services for more than 100,000 tumor patients.
该公司表示，已与全国700多家医院合作，为超过10万名肿瘤患者提供基因检测服务。这句话的翻译如下：
Precision medicine is a medical model for high-efficiency, low-cost prevention and treatment of diseases tailored to individual patients based on their genetic signature.
精准医疗是一种医疗模式，根据患者的遗传特征，为个体患者量身定制高效、低成本的疾病预防和治疗方法。
Currently, domestic precision medicine companies mainly focus on detecting specific genetic loci, to decide whether certain targeted drug can be used.
目前，国内精准医疗公司主要集中在特定基因位点的检测上，以决定是否可以使用某种靶向药物。这句话的意思是说，中国国内的精准医疗企业大多致力于检测人体内的某些特定基因变异或标记，以此来判断患者是否适合使用某种特定的、针对这些变异设计的靶向药物。这种做法是精准医疗的核心理念之一，即根据患者的个体遗传信息来制定个性化治疗方案。
The report also concluded the healthcare industry will become more intelligent with the rapid development of genetic technology and AI Medicare.
该报告还得出结论，随着基因技术和人工智能在医疗领域的快速发展，医疗行业将变得更加智能化。
CEC Capital acted as the exclusive financial advisor.3D Medicines utilizes automated molecular diagnostics and artificial intelligence to help physicians leverage genetic information to tailor treatment to individual patients.
Founded in 2015, EdiGene has established four gene editing based platforms and is advancing its early stage programs into clinical development for patients with genetic diseases and cancer.
Through standardized genetic testing, family genetic risk and the birth rate of new patients will be minimized, he said.
The working group is now cooperating with related organizations and the media to increase public awareness, publicizing that it is a preventable and controllable disease, as a couple can get genetic counseling before they get pregnant.
CNBG, Sinopharm's subsidiary for vaccine and biological medicine, is also developing a genetic engineering vaccine against the virus, which is still undergoing preclinical research.
The genetic system can complete the entire novel coronavirus detection process－from sample extraction to diagnosis－within 20 hours.
Wang's company, which has expertise in genetic solutions for cancer treatment, has a detection kit for novel coronavirus using PCR-fluorescence probing that received CE marking in late March.
Chinese biotech and IVD companies invested heavily into the development and production of new test kits and genetic devices for rapid pathogen detection, even when a lack of testing resources hindered prevention and control of COVID-19 in China.
Chinese genetic giant BGI Group's Real-Time Fluorescent RT-PCR kits for detecting SARS-CoV-2, which is also known as 2019-nCoV, have become commercially available in markets recognizing CE marking since Feb 26, following approval from China's National Medical Products Administration in late January.
Annual rankings by the Genetic Engineering & Biotechnology News, a US-based industry journal, showed Amgen was ranked first among biopharmaceutical companies in the world for 2019 for the second time.
China has a huge genetic testing market that continues to grow at a high speed.
Chinese big data and analysis service provider Analysys expects that the genetic testing market in China will reach 65.95 billion yuan by 2022.
For example, one drug that had been approved in the United States and Europe is to treat hereditary angioedema, a severe genetic disease creating immune reactions.
We're also expecting drugs for patients suffering from Fabry (a rare disorder that arises from a deficiency of a particular enzyme) and Gaucher disease (a rare genetic disorder that results in serious bone damage and even death).
According to the company, it analyzed every strain of probiotics on the genetic level, and screened out those strains that can survive in a human intestine and benefit the human body.
Jiang Hui, chief operation officer of MGI, said the firm plans to use the fund to develop and manufacture new types of genetic sequencers, as well as market promotion of the genomics sequencing industry.
So far, it has delivered 1,100 genetic sequencers to 16 countries and regions.
In addition, Jackson Laboratory also announced it would team up with Xi'an Jiaotong University in an effort to use the most advanced genetic and cell engineering technologies to develop novel therapies for treating human diseases, as well as evaluate cancer therapy options and enhance the understanding of anti-cancer drug resistance in patients.
"I am looking forward to collaborating with Xi'an Jiaotong University to develop and implement critical tools for clinicians in Xi'an, China to help them make more accurate diagnoses of genetic tests as well as accelerate the development and translation of precision medicine solutions for treating human diseases," said Charles Lee, scientific director of Jackson Laboratory for Genomic Medicine.
The genetic institution said the letter contains false information.
To test the beverage's raw materials and identify its genetic ingredients, the company developed a DNA barcode identification system in 2014.
The a2 Milk brand is not a product of a technological process or genetic engineering.
(Genomics is the study of structure, function, evolution and mapping of genes or genetic material; proteomics is the study of the set of proteins that are in, or can be expressed by, a cell, tissue or organism; and metabolomics is the study of substances called metabolites formed in, or necessary for, metabolism.
By using genetic testing, molecular imaging and other medical technologies, precision medicine analyzes a patient's genetic makeup, medical history and lifestyle, before offering customized prevention and treatment for diseases such as cancer.
The company provides a range of research services, from biologics－like gene therapy, which is the manipulation of missing or defective cells to correct genetic disorders－to supporting the development of medical device products, such as testing for material and product efficiency.
Jiang Zefei, a doctor specialized in breast cancer at People's Liberation Army 307 Hospital in Beijing, said with the help of precise genetic test doctors can provide more precise treatment to some of their patients, such as avoiding prescribing ineffective drugs.
Jiang Zefei, a doctor specializing in breast cancer at People’s Liberation Army 307 Hospital in Beijing, said with the help of precise genetic testing doctors can provide more precise treatment to some of their patients, such as avoiding prescribing ineffective drugs.
The California-based company manufactures and markets next-generation genetic sequencing technology for customers such as healthcare providers, research centers and pharmaceutical firms.
"Our software combines genetic information with clinical data and our algorithms and interpretation tools allow us to identify the likely mutations that are involved in that disease," Weaver said.
Along with a prolific level of DNA sequencing, China is moving forward with a precision-based medicine initiative, and researching how drugs affect different people in different ways by analyzing clinical data, health records and genetic information.
Gene research is not only an effective way to prevent birth defects and discover genetic diseases in their early stages.
It can also provide drugs and treatment plans tailored to a person's unique genetic code and environmental exposure, said Xu Ruiqi, general-manager of BGI's Shanghai branch, a world-leading genome sequencer.
Key genetic collections have been continuously selected for over five generations, with an annual capacity to breed 100,000 pairs of high-quality shrimp, filling a gap in the domestic market and overcoming the challenge from shrimp breeding technologies being monopolized for years by foreign entities, the company said.
Fields like brain-like intelligence, quantum information and genetic technology will likely gain greater support," said Luo Zhiheng, chief economist of Guangzhou, Guangdong province-based Yuekai Securities.
Key genetic collections have been continuously selected for over five generations, with an annual capacity to breed 100,000 pairs of high-quality shrimp, filling a gap in the domestic market and breaking the bottleneck of white leg shrimp breeding technologies that had been monopolized by foreign entities for years, said the company.
Formed by more than 130 plants to date owned by various companies, the Global Lighthouse Network is a community of manufacturers applying advanced technologies to speed up and spread the smart adoption of fourth industrial revolution technologies — a fusion of artificial intelligence, robotics, the internet of things, blockchain, 3D printing, genetic engineering, quantum computing and other technologies — to their industries worldwide.
The event also featured the launch of "Hearing Crystal Sound without Obstacles" Hearing Loss Genetic Testing and Hearing Aid in Lao PDR, a project that aims to help 300 relatives of people with hereditary deafness in the Southeast Asian country with genetic testing to prevent and intervene with the disease, and donate hearing aids for 100 hearing-impaired people there.
He also hoped that further liberalization would be considered in areas such as cloud computing, internet services, agricultural biotechnology, human genetic material, legal services, media, and entertainment.
More efforts will also be made to cultivate the next-generation technologies like quantum communications and genetic technology.
The high-throughput sequencing genetic testing solutions not only detect infection pathogens, but identify key drug resistance genes and virulence genes, suitable for inpatients and critical patients.
Zhang Wei, senior vice-president of BOE Technology Group Co Ltd and chief growth officer of BOE Health, said during the 2023 Future Health Forum held by MIT Technology Review in Hangzhou: "Taking advantage of artificial intelligence, big data and biotechnology, every patient can be offered a treatment plan that best suits them based on their own genetic, physical, psychological, lifestyle and health data.
The grassroots-level public welfare activity offers free colorectal cancer genetic testing services for residents aged between 40 and 75 in the county.
"Although the Chinese people are hardworking and our labor costs are relatively low, relying on our team's efforts alone to cultivate new varieties was not enough," Li said, explaining that the genetic diversity of the country's proprietary plants was not high previously, making it difficult to produce high-quality varieties.
The plan has promoted the incorporation of advanced technologies such as genetic testing, for example, into disease prevention, he said.
Crops made with molecular breeding use genetic engineering to evaluate gene function, but they are not classified as genetically modified since the first step in their development is pollination.
In a new plan to spur the bioeconomy during the 14th Five-Year Plan period (2021-25), the National Development and Reform Commission said it is necessary to promote deep integration of advanced technologies such as genetic testing and disease prevention, and to carry out early screening programs for major diseases, including tumors.
Zhou Jun, CEO of Berry Oncology, a leading Chinese company in genetic testing and early screening of tumors, said a root cause for investors' sustained enthusiasm for early cancer screening is that although various innovative therapies have been made available in the market in recent years for cancer, once the disease progresses to the middle and late stages, the benefits from drugs will become very limited, while related expenditures at both the individual level and the society level can be huge.
Cao Xiaofeng, another academician of the Chinese Academy of Sciences, said the competition for genetic resources is becoming increasingly fierce.
"Countries and multinational companies are ramping up efforts to carry out research and development of gene function and genetic diversity while utilizing the crops," Cao said.
Precision medicine is a model for high-efficiency, low-cost prevention and treatment of illnesses tailored to individual patients and based on their genetic signature.
Currently, domestic precision medicine companies mainly focus on detecting specific genetic markers to decide whether certain targeted drugs are used.
On Aug 22, a genetic variation detection kit co-developed by OrigiMed and German pharmaceutical giant Bayer was approved by the National Medical Products Administration.
"Liu added that if the treatment process for each patient is "digitized and structured", big data from genetic testing is "structured, integrated and comprehensively analyzed" and individual treatments are "expanded into replicable innovative treatment strategies", then precision medicine will make further strides in promoting cancer treatment.
Hot topics include internet hospitals that provide remote consultations, electronic medical records, 3D printing, wearable devices and genetic big data.
She said some subsectors, such as genetic sequencing, medical imaging, new drug development, early cancer research, assisted diagnosis and next-generation sequencing technology, are developing rapidly, leading to a corresponding demand for talent.
她指出，诸如基因测序、医学成像、新药研发、早期癌症研究、辅助诊断及下一代测序技术等子领域正快速发展，从而对相关人才产生了相应的需求。
It claimed it has cooperated with more than 700 hospitals nationwide to provide genetic testing services for more than 100,000 tumor patients.
该公司宣称已与全国超过700家医院展开合作，为超过10万名肿瘤患者提供了基因检测服务。
Progress in science and technology also brings more possibilities for disease care such as genetic and cell therapeutics for diseases that were once considered untreatable, he added.
他补充说，科学和技术的进步也为疾病的治疗带来了更多的可能性，例如基因和细胞疗法可以治疗一些曾经被认为无法治愈的疾病。
In light of the COVID-19 pandemic, experts are training their sights on how AI can help improve the public health system through enhanced epidemic research, genetic testing and drug development.
"Wang Sizhen, co-founder and CEO of Genetron Holdings Ltd, a Beijing-based company with expertise in genetic solutions, said China has unique advantages in developing its medical device industry because the development of new products relies heavily on quality data from clinical practice and clinical experiments.
Some Chinese companies are already ranking among a select number worldwide that can develop and produce the industry's most cutting-edge next-generation sequencing systems and kits, while the genetic testing service market in China is already dominated by Chinese firms.
In the application of genetic engineering to the pharmaceutical sector, Chinese companies have participated deeply in the entire industry chain, from drug testing and development to clinical trials and diagnostics.
Certain immunotherapy products, vaccines, genetic materials and transgenic organisms will also be exempt.
The city will also provide prenatal genetic testing for women who have a second child in the city, and the women will get 300 yuan ($44) in subsidies for medical checkups during the pregnancy.
The woman, surnamed Liu, once had to abort her deformed fetus and is now trying to determine if the incident was due to genetic problems.
The platform integrates functions such as online medical consultation, examination, genetic big data analysis, and genetic information interpretation, and is aimed at making high-quality medical service accessible to patients across the country.
During the consultation on Thursday, Huang's team required only nine minutes to download the genetic testing data of the woman and her family members as the system was powered by 5G technology.
The platform then took just 30 minutes to complete an analysis of the patient's genetic data.
"This technology makes producing a genetic report as fast as producing a report of basic blood indicators.
Patients can obtain sufficient genetic evidence for birth counseling in just one visit to the doctors," Huang said.
Wan Gang, vice-chairman of the National Committee of the Chinese People's Political Consultative Conference, and chairman of the China Association for Science and Technology, said AI-powered technologies have been widely applied in a range of sectors, such as genetic testing, research and development of new drugs and vaccines, noncontact remote temperature screening, intelligent recognition and medical imaging analysis during the pandemic.
As the country continues to facilitate financing for technology companies, Shi said Vito Diagnostics is now looking to raise further tens of millions of yuan to enable its "bolder ideas" in genetic testing and prenatal screening, after it completed its pre-A round of funding worth tens of millions of yuan last year.
After the split, the group will focus on the research and development of genetic engineering drugs and Chinese patent medicine, as well as the real estate business, while BCHT will focus on the research, production and distribution of vaccines for humans.
Aside from vaccine companies, those associated with genetic technology, immunotherapy, generic drugs, cancer treatment, influenza treatment and private hospitals all saw declines.
Legend has weighed biochemical and genetic testing over medical services and medical equipment in terms of investment.
In addition he believes new technology, such as mobile internet, big data, AI and genetic tests, are changing consumer behaviors, service methods and sales channels in China.
Gene research is not only an effective way to prevent birth defects and diagnose genetic diseases at an early stage, but also of great significance in the treatment of diseases and protection of bio-diversity.
Founded in 1999, the gene sequencing firm offers a wide portfolio of genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare.